Dopamine contamination of infused tyramine

Clinical Chemistry

Volumn 51, Issue 9, 2005, Pages 1733-1735

  Holmes, Courtney ^a,c   Moak, Jeffrey ^b   Eldadah, Basil ^a   Zimmerly, Ella ^a   Sharabi, Yehonatan ^a   Goldstein, David S ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^c MSC 1620 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; TYRAMINE;

ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; BLOOD SAMPLING; CONTAMINATION; DOPAMINE METABOLISM; EXTRACELLULAR FLUID; HUMAN; HUMAN CELL; RISK ASSESSMENT; VASCULAR SMOOTH MUSCLE;

ADULT; DOPAMINE; DRUG CONTAMINATION; DRUG STORAGE; HUMANS; INFUSIONS, INTRAVENOUS; TIME FACTORS; TYRAMINE;

EID: 24144459069     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2005.054361     Document Type: Article

References (13)

1. Scriven AJI, Dollery CT, Murphy MB, Macquin I, Brown MJ. Blood pressure and plasma norepinephrine concentrations after endogenous norepinephrine release by tyramine. Clin Pharmacol Ther 1983;33:710-6.
2. Bianchetti MG, Minder I, Beretta-Piccoli C, Meier A, Weidmann P. Effects of tyramine on blood pressure and plasma catecholamines in normal and hypertensive subjects. Klin Wochenschr 1982;60:465-70.
3. Goldstein DS, Nurnberger J Jr, Simmons S, Gershon ES, Polinsky R, Keiser HR. Effects of injected sympathomimetic amines on plasma catecholamines and circulatory variables in man. Life Sci 1983;32:1057-63.
4. Jacob G, Costa F, Vincent S, Robertson D, Biaggioni I. Neurovascular dissociation with paradoxical forearm vasodilation during systemic tyramine administration. Circulation 2003;107:2475-9.
5. 18F]fluorodopamine in humans. Clin Exp Hypertens 1997;19:155-61.
6. Goldstein DS, Holmes C, Jacob G, Costa F, Vincent S, Robertson D, et al. Vasodilation during systemic tyramine administration. Circulation 2004; 109:E17-8.
7. Holmes C, Eisenhofer G, Goldstein DS. Improved assay for plasma dihydroxyphenylacetic acid and other catechols using high-performance liquid chromatography with electrochemical detection. J Chromatogr B Biomed Appl 1994;653:131-8.
8. Goldstein DS, Cannon RO, Zimlichman R, Keiser HR. Clinical evaluation of impedance cardiography. Clin Physiol 1986;6:235-51.
9. Os I, Kjeldsen SE, Westheim A, Lande K, Norman N, Hjermann I, et al. Endocrine and haemodynamic responses to graded dopamine infusion in essential hypertension. Scand J Clin Lab Invest 1987;47:371-7.
10. Meek JV, Martin DS, D'Aunno DS, Waters WW. Pressor response to intravenous tyramine is a marker of cardiac, but not vascular, adrenergic function. J Cardiovasc Pharmacol 2003;41:126-31.
11. Crout JR, Muskus AJ, Trendelenburg U. Effect of tyramine on isolated guinea-pig atria in relation to their noradrenaline stores. Br J Pharmacol 1962;18:600-11.
12. Brodie BB, Cho AK, Stefano FJ, Cessa GL. On mechanisms of norepinephrine release by amphetamine and tyramine and tolerance to their effects. Adv Biochem Psychopharmacol 1969;1:219-38.
13. Hermida-Ameijeiras A, Mendez-Alvarez E, Sanchez-Iglesias S, Sanmartin-Suarez C, Soto-Otero R. Autoxidation and MAO-mediated metabolism of dopamine as a potential cause of oxidative stress: role of ferrous and ferric ions. Neurochem Int 2004;45:103-16.